| FDA panel greenlights Boehringer's stroke prevention drug Pradaxa - Cardiovascular Business |
|
|
Cardiovascular BusinessThe FDA's Cardiovascular and Renal Drug advisory committee has has unanimously voted, nine to zero, in favor of Boehringer Ingelheim Pharmaceuticals' ... read more |